L
Luca Agnelli
Researcher at University of Milan
Publications - 130
Citations - 4901
Luca Agnelli is an academic researcher from University of Milan. The author has contributed to research in topics: Gene expression profiling & IGHV@. The author has an hindex of 43, co-authored 119 publications receiving 4239 citations. Previous affiliations of Luca Agnelli include Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.
Papers
More filters
Journal ArticleDOI
Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
Marta Lionetti,Marta Biasiolo,Luca Agnelli,Katia Todoerti,Laura Mosca,Sonia Fabris,Gabriele Sales,Giorgio Lambertenghi Deliliers,Silvio Bicciato,Luigia Lombardi,Stefania Bortoluzzi,Antonino Neri +11 more
TL;DR: The integrative analysis based on computational target prediction and miRNA/mRNA profiling defined a network of putative functional miRNA-target regulatory relations supported by expression data that were found significantly associated with the altered expression of miRNAs located in the involved regions.
Journal ArticleDOI
Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers
Francesca Cottini,Teru Hideshima,Chunxiao Xu,Martin Sattler,Martina Dori,Luca Agnelli,Elisa Ten Hacken,Maria Teresa Sabrina Bertilaccio,Elena Antonini,Antonino Neri,Maurilio Ponzoni,Magda Marcatti,Paul G. Richardson,Ruben D. Carrasco,Alec C. Kimmelman,Kwok-Kin Wong,Federico Caligaris-Cappio,Giovanni Blandino,W. Michael Kuehl,Kenneth C. Anderson,Giovanni Tonon +20 more
TL;DR: This work finds pervasive DNA damage in hematologic malignancies, including multiple myeloma, lymphoma and leukemia, which leads to activation of a p53-independent, proapoptotic network centered on nuclear relocalization of ABL1 kinase, and identifies a new synthetic-lethal strategy to selectively target cancer cells presenting with endogenous DNA damage and low YAP1 levels.
Journal ArticleDOI
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes
Roberto Piva,Elisa Pellegrino,Michela Mattioli,Luca Agnelli,Luigia Lombardi,Francesco Boccalatte,Giulia Costa,Bruce Ruggeri,Mangeng Cheng,Roberto Chiarle,Giorgio Palestro,Antonino Neri,Giorgio Inghirami +12 more
TL;DR: It is proved that an experimentally controlled and functionally validated GEP analysis represents a powerful tool to identify novel pathogenetic networks and validate biologically suitable target genes for therapeutic interventions.
Journal ArticleDOI
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity.
Nicola Amodio,Maria Angelica Stamato,Giada Juli,Eugenio Morelli,Mariateresa Fulciniti,Martina Manzoni,Martina Manzoni,Elisa Taiana,Elisa Taiana,Luca Agnelli,Luca Agnelli,Maria Eugenia Gallo Cantafio,Enrica Romeo,Lavinia Raimondi,Daniele Caracciolo,Valeria Zuccalà,Marco Rossi,Antonino Neri,Antonino Neri,Nikhil C. Munshi,Nikhil C. Munshi,Pierosandro Tagliaferri,Pierfrancesco Tassone,Pierfrancesco Tassone +23 more
TL;DR: A crucial role of MALAT1 in the regulation of the proteasome machinery is demonstrated, and proof-of-concept that its targeting is a novel powerful option for the treatment of MM is provided.
Journal ArticleDOI
Gene Expression Profiling Uncovers Molecular Classifiers for the Recognition of Anaplastic Large-Cell Lymphoma Within Peripheral T-Cell Neoplasms
Roberto Piva,Luca Agnelli,Elisa Pellegrino,Katia Todoerti,Valentina Grosso,Ilaria Tamagno,Alessandro Fornari,Barbara Martinoglio,Enzo Medico,Alberto Zamò,Fabio Facchetti,Maurilio Ponzoni,Eva Geissinger,Andreas Rosenwald,Hans Konrad Müller-Hermelink,Christiane De Wolf-Peeters,Pier Paolo Piccaluga,Stefano Pileri,Antonino Neri,Giorgio Inghirami +19 more
TL;DR: It is proved that experimentally controlled GEP in ALCL cell lines represents a powerful tool to identify meaningful signaling networks for the recognition of systemic primary T-NHL.